Reuters: Bill Smead on Amgen
Amgen sales rise, but shares off as investors await obesity data By Deena Beasley For more information go to reuters.com. Stocks mentioned: AMGN The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past